Madrigal Pharmaceuticals (MDGL) Leases (2019 - 2026)
Madrigal Pharmaceuticals (MDGL) reported Leases of $6.2 million for Q1 2026, up 193.98% year-over-year from $2.1 million in Q1 2025, and up 25.59% on a QoQ basis from $4.9 million in Q4 2025.
Madrigal Pharmaceuticals (MDGL) has 8 years of Leases data on file, last reported at $6.2 million in Q1 2026.
- Quarterly Leases rose 193.98% year-over-year to $6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 million (up 193.98% YoY) and the FY2025 annual result came in at $4.9 million, up 105.71% from the prior year.
- Leases rose to $6.2 million in Q1 2026 per MDGL's latest filing, from $4.9 million in the prior quarter.
- Across five years, Leases topped out at $6.2 million in Q1 2026 and bottomed at $411000.0 in Q2 2023.
- The 5-year median for Leases is $1.7 million (2023), against an average of $2.4 million.
- The widest annual swing landed in 2023, when Leases slumped 61.12%; it then jumped 302.61% in 2025.
- Tracing MDGL's Leases over 5 years: stood at $602000.0 in 2022, then jumped by 184.55% to $1.7 million in 2023, then soared by 40.16% to $2.4 million in 2024, then jumped by 105.71% to $4.9 million in 2025, then advanced by 25.59% to $6.2 million in 2026.
- Per Business Quant, the three latest MDGL Leases figures stand at $6.2 million (Q1 2026), $4.9 million (Q4 2025), and $5.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Madrigal Pharmaceuticals | 14.44 Bn | 14.20 Bn | - | 6.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.20 Mn |
| Dec 31, 2025 | 4.94 Mn |
| Sep 30, 2025 | 5.39 Mn |
| Jun 30, 2025 | 5.86 Mn |
| Mar 31, 2025 | 2.11 Mn |
| Dec 31, 2024 | 2.40 Mn |
| Sep 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 1.84 Mn |
| Jun 30, 2023 | 411,000.00 |
| Mar 31, 2023 | 653,000.00 |
| Dec 31, 2022 | 602,000.00 |
| Sep 30, 2022 | 831,000.00 |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 696,000.00 |
| Dec 31, 2021 | 797,000.00 |
| Sep 30, 2021 | 897,000.00 |
| Jun 30, 2021 | 997,000.00 |
| Mar 31, 2021 | 707,000.00 |
| Dec 31, 2020 | 785,000.00 |
| Sep 30, 2020 | 863,000.00 |
| Jun 30, 2020 | 520,000.00 |
| Mar 31, 2020 | 598,000.00 |
| Dec 31, 2019 | 675,000.00 |
| Sep 30, 2019 | 751,000.00 |
| Jun 30, 2019 | 826,000.00 |
| Mar 31, 2019 | 930,000.00 |